SCHEMBL18564827

SCHEMBL18564827

Cn1c2ccc(N(c3ccccc3)c3ccc(-c4ccccc4)cc3)cc2c2c3ccccc3ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.35
▸ NQO2 P16083 1/20 0.35
▸ TSPO P30536 1/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ PTGES O14684 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ WEE1 P30291 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ PABPC1 P11940 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32
▸ AHR P35869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564938 0.95 SLC2A1 (0.34) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564878 0.95 TSPO (0.39) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564824 0.95 TSPO (0.39) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564683 0.95 GPR3 (0.38) SLC2A1NQO2GPR3KMT2AHSD17B10
SCHEMBL18564935 0.94 TSPO (0.37) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564960 0.94 TSPO (0.37) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564769 0.94 TSPO (0.38) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18564862 0.94 TSPO (0.38) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18565029 0.91 TSPO (0.35) SLC2A1NQO2TSPOGPR3KMT2A
SCHEMBL18565040 0.91 TSPO (0.35) SLC2A1NQO2TSPOGPR3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 SLC2A1 4679/4885NQO2 4146/4885TSPO 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback